Mind-Body Therapies in Primary Health Care

Status Not yet recruiting

Clinical Trial Summary

Mental disorders are among the most common causes of disability globally. Given the high prevalence of mental disorders (57.0%) in Azores islands (Portugal), local primary health care (PHC) services should encourage the implementation of complementary interventions for prevention of this type of disorders. New approaches, such as mind-body therapies, have been studied and recommended for prevention and treatment of numerous chronic diseases, particularly mental disorders.

This study aims to evaluate the feasibility and effectiveness of a 6-months mind-body therapies (yoga, qigong and pilates), in users of Ponta Delgada Health Center (PDHC) with perceived distress, compared to a waiting list control.

Clinical Trial Description

VIVE mind will be a pragmatic, single-center, randomized controlled trial.

Users of PDHC with perceived distress (PSS-10), aged 18 years or over, will be recruited and randomly assigned into experimental and waiting list control group, in a 1:1 ratio. The recruitment of participants will be held in PDHC by health professional (e.g., family medicine doctors, nurses, nutritionists, psychologists, etc). After signed informed consent and baseline measures, experimental group will participate in body-mind sessions (yoga, qigong or pilates), oriented by certified instructors, during 6-months. Each participant should attend only one of the therapies, in order to guarantee a differentiated evaluation. In every session, it will be evaluated the participants' adherence and theirs perceived enjoyment and exertion. The other outcomes (primary and secondary) will be analyzed through a face-to-face contact, in three different moments: baseline (T0), post-intervention (at month 6, T1) and 6-month follow-up (at month 12, T2). The control group will not participate in any specific intervention, but will receive the body-mind intervention after the experimental period. An intention-to-treat and per protocol analysis will be performed to analyze intervention effectiveness and efficacy. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04058119
Study type	Interventional
Source	Unidade de Saude da Ilha de Sao Miguel
Contact	Sara B. Ponte, MD
Phone	+351 296 960 286
Email	Sara.CB.Ponte@azores.gov.pt
Status	Not yet recruiting
Phase	N/A
Start date	February 2020
Completion date	December 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04680611` - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Completed	`NCT05703087` - Positive Cueing in Knee Arthroplasty.	N/A
Completed	`NCT02629016` - Stress Reduction: A Pilot Study With Adolescents	N/A
Completed	`NCT02541240` - Effects of an Intervention to Enhance Resilience in Physical Therapy Students	N/A
Completed	`NCT01406028` - Does Emotional Support Decrease In Vitro Fertilization Stress?	N/A
Completed	`NCT00121160` - Health SMART (Stress Management and Relaxation Training) to Improve Vaccine Immune Response	Phase 1
Completed	`NCT02621775` - Effectiveness of Two Stress Management Programs in Adaptation Disorder With Anxiety (ADA)	N/A
Recruiting	`NCT04474418` - Psychometric Characterization of Patients With Cardiac Arrhythmias
Completed	`NCT03310112` - Mindfulness Training in U.S. Army Cohorts	N/A
Terminated	`NCT03893617` - Brief Stresses Experimental Study	Phase 1
Active, not recruiting	`NCT05542498` - Promoting Stress Management and Engagement in Introductory Physics Courses With Mindfulness and Relaxation	N/A
Completed	`NCT02394899` - Improving Parental Psychosocial Functioning and Early Developmental Outcomes in Children With Sickle Cell Disease	N/A
Terminated	`NCT00962273` - The Pandemic Stress Vaccine: A Resource to Enhance the Resilience of Healthcare Workers Facing an Infectious Outbreak	N/A
Completed	`NCT00451126` - Moderating Impact of Various Emotion Personality Factors on Salivary Cortisol Response to a TSST	N/A
Completed	`NCT06051500` - Psychological and Physiological Effects of Different Objects of Breath Meditation	N/A
Completed	`NCT02801045` - Art Therapy in Palliative Care: Study of Identification and Understanding of the Mechanisms of Change in the Patient	N/A
Completed	`NCT03308344` - Mindfulness Training in Military Spouses	N/A
Recruiting	`NCT06029348` - Cerebrovascular Health and Resilience in Midlife	N/A
Completed	`NCT05869006` - The Effect of Designed SIA Instrument Supported Interpersonal Relations-Based Group Practice on Psychological Well-Being and Creativity	N/A
Completed	`NCT04484649` - Sleeping Healthy/Living Healthy Development	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Mind-Body Therapies in Primary Health Care — VIVEmind

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms